PREVITALI, STEFANO CARLO
 Distribuzione geografica
Continente #
AS - Asia 2.571
NA - Nord America 1.864
EU - Europa 924
SA - Sud America 657
AF - Africa 48
OC - Oceania 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 6.067
Nazione #
US - Stati Uniti d'America 1.780
SG - Singapore 1.120
CN - Cina 742
BR - Brasile 575
HK - Hong Kong 348
IT - Italia 309
VN - Vietnam 148
SE - Svezia 131
DE - Germania 100
RU - Federazione Russa 84
GB - Regno Unito 68
IN - India 51
AT - Austria 47
FI - Finlandia 45
CA - Canada 40
NL - Olanda 38
MX - Messico 31
AR - Argentina 30
BD - Bangladesh 25
JP - Giappone 23
FR - Francia 21
ZA - Sudafrica 20
TR - Turchia 19
EC - Ecuador 17
IQ - Iraq 16
ES - Italia 14
PL - Polonia 14
ID - Indonesia 12
UZ - Uzbekistan 10
IE - Irlanda 9
PY - Paraguay 9
IR - Iran 8
LT - Lituania 8
SA - Arabia Saudita 8
VE - Venezuela 7
CL - Cile 6
CO - Colombia 6
CZ - Repubblica Ceca 5
KE - Kenya 5
MA - Marocco 5
SI - Slovenia 5
UA - Ucraina 5
JO - Giordania 4
NP - Nepal 4
PS - Palestinian Territory 4
AE - Emirati Arabi Uniti 3
BG - Bulgaria 3
BO - Bolivia 3
DZ - Algeria 3
HU - Ungheria 3
JM - Giamaica 3
PE - Perù 3
PK - Pakistan 3
RO - Romania 3
TN - Tunisia 3
AL - Albania 2
AU - Australia 2
BE - Belgio 2
BH - Bahrain 2
DO - Repubblica Dominicana 2
EG - Egitto 2
GE - Georgia 2
GT - Guatemala 2
HN - Honduras 2
KG - Kirghizistan 2
KW - Kuwait 2
LB - Libano 2
NG - Nigeria 2
PH - Filippine 2
SN - Senegal 2
AO - Angola 1
AZ - Azerbaigian 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CG - Congo 1
CH - Svizzera 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CY - Cipro 1
GR - Grecia 1
HR - Croazia 1
IL - Israele 1
KZ - Kazakistan 1
LK - Sri Lanka 1
MD - Moldavia 1
MT - Malta 1
MY - Malesia 1
OM - Oman 1
PA - Panama 1
RE - Reunion 1
RS - Serbia 1
SC - Seychelles 1
SV - El Salvador 1
TJ - Tagikistan 1
TL - Timor Orientale 1
TT - Trinidad e Tobago 1
TW - Taiwan 1
UY - Uruguay 1
Totale 6.066
Città #
Dallas 722
Singapore 527
Hong Kong 346
Ashburn 262
Shanghai 160
Hefei 149
Beijing 148
Milan 103
New York 66
Ho Chi Minh City 58
São Paulo 57
Los Angeles 49
Lawrence 43
Princeton 43
Moscow 36
Nuremberg 36
Helsinki 27
Hanoi 26
Orem 22
Tokyo 22
Brooklyn 21
Santa Clara 21
Vienna 21
Amsterdam 20
Boardman 20
Washington 19
Denver 18
Poplar 18
Rome 18
Belo Horizonte 17
Montreal 17
Munich 17
Chicago 15
Cesano Boscone 14
Hangzhou 14
Phoenix 14
Boston 13
Warsaw 13
Zhengzhou 13
Chennai 12
Johannesburg 12
Lappeenranta 12
Rio de Janeiro 12
Shenzhen 12
Curitiba 11
Falkenstein 11
Guangzhou 11
Houston 11
Randolph Township 11
San Jose 11
Seattle 11
Atlanta 10
Toronto 10
Dublin 9
London 9
Manchester 9
Stockholm 9
Assago 8
Brasília 8
Salvador 8
Tashkent 8
Ankara 7
Baghdad 7
Bengaluru 7
Des Moines 7
Guayaquil 7
Haiphong 7
Santo André 7
Thái Bình 7
Asunción 6
Biên Hòa 6
Buenos Aires 6
Charlotte 6
Frankfurt am Main 6
Guarulhos 6
Mexico City 6
Mumbai 6
Naples 6
San Francisco 6
Skokie 6
Turku 6
Brescia 5
Duque de Caxias 5
Fortaleza 5
Goiânia 5
Islington 5
Jinan 5
Nairobi 5
Porto Alegre 5
Querétaro 5
Quito 5
Riyadh 5
Romagnano Sesia 5
Xi'an 5
Amman 4
Arapongas 4
Bergamo 4
Blumenau 4
Bologna 4
Campinas 4
Totale 3.667
Nome #
Multidisciplinary Screening of a Novel Founder LMNA Mutation Associated With Cardiomyopathy in a Geographic Isolate 215
Genotype and phenotype spectrum of Charcot-Marie-Tooth disease due to mutations in SORD 130
Niacin ameliorates Charcot-Marie-Tooth 4B1 neuropathy without interfering with nerve regeneration 126
JAB1 deletion in oligodendrocytes causes senescence-induced inflammation and neurodegeneration in mice 122
Disease Progression in Charcot-Marie-Tooth Disease Type 4B (CMT4B) Associated With Mutations in Myotubularin-Related Proteins 2 and 13 112
Jab1 regulates Schwann cell proliferation and axonal sorting through p27. 106
Nusinersen safety and effects on motor function in adult spinal muscular atrophy type 2 and 3 106
Cardiac and Neuromuscular Features of Patients with LMNA-Related Cardiomyopathy 91
Impaired turnover of hyperfused mitochondria in severe axonal neuropathy due to a novel DRP1 mutation 88
A new double-trouble phenotype: fascioscapulohumeral muscular dystrophy ameliorates hereditary spastic paraparesis due to spastin mutation. 85
Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophy 85
LAMA2 Neuropathies: Human Findings and Pathomechanisms From Mouse Models 80
Mutations in MYO9B are associated with Charcot–Marie–Tooth disease type 2 neuropathies and isolated optic atrophy 75
A multicenter retrospective study of charcot-marie-tooth disease type 4B (CMT4B) associated with mutations in myotubularin-related proteins (MTMRs) 71
Overcoming therapeutic challenges: Successful management of a supposedly triple seronegative, refractory generalized myasthenia gravis patient with efgartigimod 71
The mitochondrial protease AFG3L2 is essential for axonal development 71
Begelomab for severe refractory dermatomyositis: A case report 70
Charcot-Marie-Tooth type 4B demyelinating neuropathy: deciphering the role of MTMR phosphatases 69
Brain connectivity abnormalities extend beyond the sensorimotor network in peripheral neuropathy 69
Corrigendum to “Going for a stroll on lurasidone: Considerations on an atypical case of acute compartment syndrome of both legs” [Heliyon 9(4) (April 2023) e15047] (Heliyon (2023) 9(4), (S2405844023022545), (10.1016/j.heliyon.2023.e15047)) 68
Alteration of the late endocytic pathway in Charcot-Marie-Tooth type 2B disease 67
Analyzing histopathological features of rare charcot-marie-tooth neuropathies to unravel their pathogenesis 67
A GENOMIC APPROACH TO IDENTIFY NEW GENES RESPONSIBLE FOR INHERITED MOTOR AND CMT2 NEUROPATHIES: A COLLABORATIVE STUDY 65
Expanding the spectrum of genes responsible for hereditary motor neuropathies 63
Prostaglandin D2 synthase modulates macrophage activity and accumulation in injured peripheral nerves 62
A novel heat shock protein 27 homozygous mutation: widening of the continuum between MND/dHMN/CMT2 59
Going for a stroll on lurasidone: Considerations on an atypical case of acute compartment syndrome of both legs 58
Dipeptidyl peptidase 4/CD26 expression in human idiopathic inflammatory myopathies reveals skeletal muscle injury and vascular inflammation 58
Mesoangioblasts at 20: From the embryonic aorta to the patient bed 57
CLINICAL AND MOLECULAR CHARACTERIZATION OF A COHORT OF PATIENTS WITH DISTAL MOTOR NEUROPATHY 55
CLINICAL CHARACTERIZATION OF A PATIENT CARRYING HINT1 MUTATION 54
Neuromyelitis optica and myotonic dystrophy type 2: a rare association with diagnostic implications 53
Muscle hypertrophy following acquired neurogenic injury: systematic review and analysis of existing literature 52
CHARCOT-MARIE-TOOTH DISEASE TYPE 4B: A MULTICENTRE RETROSPECTIVE STUDY 51
24 Month Longitudinal Data in Ambulant Boys with Duchenne Muscular Dystrophy 50
A 5-year clinical follow-up study from the Italian National Registry for FSHD 50
Corrigendum to “Going for a stroll on lurasidone: Considerations on an atypical case of acute compartment syndrome of both legs” [Heliyon Volume 9, Issue 4, April 2023, Article e15047](S2405844023022545)(10.1016/j.heliyon.2023.e15047) 49
Autocrine and immune cell-derived BDNF in human skeletal muscle: implications for myogenesis and tissue regeneration 48
Abnormal Schwann cell-axon interaction in EBF-2 "knock out" mice 48
DEFINING GENOTYPE-PHENOTYPE CORRELATIONS IN THE CMT NEUROPATHIES 48
Rimeporide as a first- in-class NHE-1 inhibitor: Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy 47
Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy 47
Phenotypic Variability Among Patients With D4Z4 Reduced Allele Facioscapulohumeral Muscular Dystrophy 45
Protein profiling reveals energy metabolism and cytoskeletal protein alterations in LMNA mutation carriers. 45
Animal Models as a Tool to Design Therapeutical Strategies for CMT-like Hereditary Neuropathies 44
The extracellular matrix affects axonal regeneration in peripheral neuropathies 43
Autoimmunity in the peripheral nervous system 43
CYTOSKELETON AND PERIPHERAL NERVE MYELINATION: A NOVEL ROLE FOR VIMENTIN 43
Categorizing natural history trajectories of ambulatory function measured by the 6-minute walk distance in patients with Duchenne muscular dystrophy 41
Hypokalemic periodic paralysis in a patient with acquired growth hormone deficiency 41
Facioscapulohumeral dystrophy 41
6 Minute Walk Test in Duchenne MD Patients with Different Mutations: 12 Month Changes 40
Vocal cord paralysis in Charcot–Marie–Tooth type 4b1 disease associated with a novel mutation in the myotubularin-related protein 2 gene: A case report and review of the literature 40
Kif13b Regulates PNS and CNS Myelination through the Dlg1 Scaffold 40
Correction to: Molecular mechanisms and therapeutic strategies for neuromuscular diseases (Cellular and Molecular Life Sciences, (2024), 81, 1, (198), 10.1007/s00018-024-05229-9) 39
A whole-brain functional network connectivity analysis in patients with hereditary and acquired peripheral neuropathy. 39
Intravenous immunoglobulin treatment in patients with chronic inflammatory demyelinating neuropathy not responsive to other treatments 39
Disruption of Mtmr2 produces CMT4B1-like neuropathy with myelin outfolding and impaired spermatogenesis 38
Vimentin regulates peripheral nerve myelination 38
Muscle MRI findings in facioscapulohumeral muscular dystrophy 38
Correction: Increased Serum Hepcidin Levels in Subjects with the Metabolic Syndrome: A Population Stydy. 38
Loss of glial fibrillary acidic protein (GFAP) impairs Schwann cell proliferation and delays nerve regeneration after damage 38
A whole-brain network analysis in patients with hereditary and acquired peripheral neuropathy 37
Longitudinal MRI quantification of muscle degeneration in Duchenne muscular dystrophy 37
Hypogonadotropic hypogonadism and peripheral neuropathy in Ebf2-null mice 37
Increased serum hepcidin levels in subjects with the metabolic syndrome: a population study 37
Pregnancy in Charcot-Marie-Tooth disease: Data from the Italian CMT national registry 37
Loss of Mtmr2 phosphatase in Schwann cells but not in motor neurons causes Charcot-Marie-tooth type 4B1 neuropathy with myelin outfoldings 36
Peripheral Nerve Development and the Pathogenesis of Peripheral Neuropathy: the Sorting Point 36
P3170Innovative approach for risk stratification of LMNA-related cardiomyopathy: results from an integrated cardiological and neurological 10-year follow-up multicentre study 36
Urokinase Plasminogen Receptor and the Fibrinolytic Complex Play a Role in Nerve Repair after Nerve Crush in Mice, and in Human Neuropathies 35
Genetic modifiers of respiratory function in Duchenne muscular dystrophy 35
Foot pad skin biopsy in mouse models of hereditary neuropathy 35
The exctracellular matrix affects axonal regeneration in peripheral neuropathies 35
Diagnosis of Duchenne Muscular Dystrophy in Italy in the last decade: Critical issues and areas for improvements 34
Loss of function MPZ mutation causes milder CMT1B neuropathy 34
CSN5/JAB1 PLAYS A ROLE IN AXONAL SORTING AND MYELINATION IN PERIPHERAL NERVE 34
Niacin-mediated Tace activation ameliorates CMT neuropathies with focal hypermyelination 34
LOSS OF FIG4 IN BOTH SCHWANN CELLS AND MOTOR NEURONS CONTRIBUTES TO CMT4J NEUROPATHY 33
VOCAL CORD PARALYSIS IN CHARCOT-MARIE-TOOTH TYPE 4B1 DISEASE ASSOCIATED WITH A NOVEL MUTATION IN THE MYOTUBULARIN-RELATED PROTEIN 2 GENE: A CASE REPORT AND REVIEW OF THE LITERATUREPPP 32
Sodium Channel Myotonia Due to Novel Mutations in Domain I of Nav1.4 32
Mesoangioblast delivery of miniagrin ameliorates murine model of merosin-deficient congenital muscular dystrophy type 1A 32
Quantitative muscle strength assessment in duchenne muscular dystrophy: longitudinal study and correlation with functional measures. 32
MODULATION OF NEUREGULIN 1 TYPE III PATHWAY TO TREAT HEREDITARY DEMYELINATING NEUROPATHIES 31
TRAFFICKING THROUGH THE ENDO-LYSOSOMAL AXIS REGULATES MYELINATION AND REPAIR IN THE PERIPHERAL NERVOUS SYSTEM 31
Myotubularin-related 2 protein phosphatase and neurofilament light chain protein, both mutated in CMT neuropathies, interact in peripheral nerve 31
CSN5/JAB1 REGULATES SCHWANN CELL-AXON INTERACTION AND PLAYS A ROLE IN PERIPHERAL NERVE DEVELOPMENT AND FUNCTION 31
Long-term natural history data in Duchenne muscular dystrophy ambulant patients with mutations amenable to skip exons 44, 45, 51 and 53 31
Merosin deficient congenital muscular dystrophy type 1A: An international workshop on the road to therapy 15-17 November 2019, Maastricht, the Netherlands 31
Expression analysis in the peripheral nerve of the myotubularin-related 2 protein phosphatase, mutated in CMT4B1 31
Intra-arterial transplantation of HLA-matched donor mesoangioblasts in Duchenne muscular dystrophy 31
Outcome measures validation for mesoangioblast transplantation in pediatric patients affected by Duchenne muscular dystrophy 31
VOCAL CORD PARALYSIS IN CHARCOT-MARIE-TOOTH TYPE 4B1 DISEASE ASSOCIATED WITH A NOVEL MUTATION IN THE MYOTUBULARIN-RELATED PROTEIN 2 GENE: A CASE REPORT AND REVIEW OF THE LITERATURE 30
ISPD mutations account for a small proportion of Italian Limb Girdle Muscular Dystrophy cases 30
Estimating the impact of COVID-19 pandemic on services provided by Italian Neuromuscular Centers: an Italian Association of Myology survey of the acute phase 30
Editorial: Current Insights Into LAMA2 Disease. 30
Dominant LMNA mutations can cause combined muscular dystrophy and peripheral neuropathy 30
Suitability of external controls for drug evaluation in Duchenne muscular dystrophy 30
GENOMIC APPROACH FOR INHERITED MOTOR AND CMT2 NEUROPATHIES: A COLLABORATIVE STUDY 29
SEVEN EXAMPLES OF EXPANDABLE CLINICAL SPECTRUM OF NEUROMUSCULAR GENES 29
Totale 5.178
Categoria #
all - tutte 37.612
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.612


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20213 0 0 0 0 0 1 1 0 0 0 0 1
2021/202234 0 0 0 7 0 8 7 2 4 0 6 0
2022/2023269 98 49 22 0 3 23 12 14 11 31 1 5
2023/2024324 7 17 40 55 31 89 8 22 0 4 6 45
2024/20252.239 128 25 114 239 110 176 396 228 318 193 142 170
2025/20263.380 541 491 792 860 555 141 0 0 0 0 0 0
Totale 6.285